Savant Capital LLC Acquires 2,438 Shares of Humana Inc. $HUM

Savant Capital LLC raised its holdings in shares of Humana Inc. (NYSE:HUM) by 22.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,485 shares of the insurance provider’s stock after buying an additional 2,438 shares during the period. Savant Capital LLC’s holdings in Humana were worth $3,297,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Cary Street Partners Investment Advisory LLC increased its stake in shares of Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 46 shares in the last quarter. Applied Finance Capital Management LLC lifted its position in Humana by 1.7% during the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider’s stock valued at $779,000 after purchasing an additional 48 shares in the last quarter. Blue Trust Inc. grew its holdings in Humana by 3.6% during the second quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock valued at $334,000 after purchasing an additional 48 shares during the period. Atlas Brown Inc. increased its position in Humana by 0.9% in the second quarter. Atlas Brown Inc. now owns 6,369 shares of the insurance provider’s stock worth $1,557,000 after buying an additional 54 shares in the last quarter. Finally, Townsquare Capital LLC increased its position in Humana by 2.8% in the first quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider’s stock worth $597,000 after buying an additional 61 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

HUM has been the subject of a number of recent research reports. Truist Financial set a $300.00 price objective on Humana in a research note on Tuesday, October 14th. Wolfe Research lifted their price target on shares of Humana from $283.00 to $313.00 and gave the company an “outperform” rating in a report on Monday, October 6th. Sanford C. Bernstein upped their price target on shares of Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Robert W. Baird decreased their price objective on shares of Humana from $300.00 to $297.00 and set a “neutral” rating on the stock in a research report on Friday, July 25th. Finally, Wall Street Zen cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $299.22.

Humana Trading Up 0.1%

Shares of HUM stock opened at $251.46 on Monday. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $30.24 billion, a price-to-earnings ratio of 19.30, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The stock’s 50-day moving average price is $278.04 and its 200-day moving average price is $258.86.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s revenue was up 11.1% on a year-over-year basis. During the same period in the prior year, the company earned $4.16 earnings per share. Equities research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. Humana’s dividend payout ratio (DPR) is 33.18%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.